A S Fisch

James Homer Wright Pathology Laboratories, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

43 publications 2011 – 2026 ORCID

Research Overview

A S Fisch is a researcher at Massachusetts General Hospital focused on identifying and understanding unique cancer types and their characteristics. Their work includes studying rare tumors in the female reproductive system, understanding the immune evasion mechanisms in head and neck cancers, and developing blood tests that can predict cancer recurrence, ultimately aiming to improve diagnosis and treatment strategies.

Publications

Adnexal Endometrioid Carcinomas With Sex Cord-Like Morphology are Frequently PAX8-Negative, SOX17-Positive, and Enriched for CTNNB1 Alterations.

2026

The American journal of surgical pathology

Lengyel K, Musick A, Fisch AS, Lin LH, Turashvili G +3 more

Plain English
Researchers studied a type of ovarian and fallopian tube cancer with a unique appearance. They found that these tumors often lack a specific marker (PAX8) that is usually present in other cancers, but they commonly express another marker (SOX17) and have mutations in a gene (CTNNB1) that affect cell behavior. This understanding is important because it helps doctors correctly identify these tumors, preventing misdiagnosis and ensuring patients receive the right treatment.

View on PubMed

DICER1-Related Primitive Polyphenotypic Neoplasm: A Report of 15 Cases of an Underrecognized Tumor of the Gynecologic Tract and Peritoneum.

2026

The American journal of surgical pathology

Devins KM, Lin LH, Fisch AS, Dias-Santagata D, Pinto A +3 more

Plain English
Researchers studied a rare type of tumor called DICER1-related primitive polyphenotypic neoplasm, which can occur in the female reproductive system and abdomen. They found 15 cases of this tumor in patients aged 10 to 77, with many showing specific cell features that made them difficult to identify. Understanding these tumors is important because recognizing their unique characteristics can lead to better diagnosis and genetic testing, especially for younger patients who may have inherited risks.

View on PubMed

Tumor microenvironment-driven immune evasion and therapeutic strategies in head and neck squamous cell carcinoma.

2026

Current opinion in oncology

Tinhofer I, Fisch AS

Plain English
Researchers studied head and neck squamous cell carcinoma, a type of cancer that grows in a unique environment that helps it evade the immune system. They found that this environment creates barriers that make existing therapies less effective. Understanding these barriers can help develop new treatment strategies that target the tumor environment, potentially improving outcomes for patients with this type of cancer.

View on PubMed

Prognostic value of tumor-informed ctDNA in HPV-independent head and neck squamous cell carcinoma.

2026

medRxiv : the preprint server for health sciences

Ruiz-Torres DA, Roberts TJ, Du P, Mendel J, Neagele S +13 more

Plain English
Researchers studied a blood test that detects tiny amounts of tumor DNA in patients with a specific type of throat cancer that is not linked to HPV. They found that when this DNA was present, patients were more likely to experience a recurrence of their cancer and had a shorter survival time. This finding is important because it suggests that this blood test could help doctors predict outcomes and make better treatment decisions for patients with this type of cancer.

View on PubMed

Prognostic Value of Tumor-Informed Circulating Tumor DNA in HPV-Independent Head and Neck Squamous Cell Carcinoma.

2026

JAMA otolaryngology-- head & neck surgery

Ruiz-Torres DA, Roberts TJ, Du P, Mendel J, Neagele S +13 more

Plain English
Researchers examined a blood test that detects tumor DNA in patients with a specific type of head and neck cancer that doesn't involve HPV. They found that when the test showed positive results after treatment, it indicated a higher chance of cancer recurrence and lower survival rates. This finding is important because it suggests that this blood test could help doctors identify patients at greater risk after treatment, potentially leading to more tailored monitoring and care.

View on PubMed

Incidence of HPV-independent second primary malignancies following treatment of HPV-associated malignancy.

2026

Oral oncology

Nyirjesy SC, Al-Inaya Y, Zhang S, Karadaghy OA, Lin DT +6 more

Plain English
Researchers looked at patients who had already been treated for a type of throat cancer linked to HPV to see if they developed other types of head and neck cancers that were not connected to HPV. They found that about 2.5% of patients did develop these second cancers years later, often in different areas of the mouth or throat, and many had received radiation and chemotherapy for their first cancer. This is important because it shows that these new cancers can have different causes than the original one, suggesting that doctors should monitor these patients long-term and consider retesting for HPV.

View on PubMed

Circulating tumor human papillomavirus DNA whole genome sequencing enables human papillomavirus-associated oropharynx cancer early detection.

2026

Journal of the National Cancer Institute

Das D, Hirayama S, Aye L, Bryan ME, Naegele S +14 more

Plain English
Researchers studied a blood test that detects HPV DNA in patients with oropharyngeal cancer, which is the most common HPV-related cancer in the U.S. They found that this test could identify the cancer in the blood up to 10 years before a diagnosis, making it a potentially effective early detection method. This is important because early detection can lead to better treatment outcomes and reduced risk of serious health issues related to the cancer.

View on PubMed

Clinical validation of an HPV whole genome sequencing assay for molecular residual disease detection in HPV-associated head and neck cancer patients treated with surgery.

2025

medRxiv : the preprint server for health sciences

Hirayama S, Al-Inaya Y, Bryan ME, Das D, Aye L +19 more

Plain English
Researchers studied how to better detect leftover cancer after surgery in patients with HPV-related head and neck cancers. They found that a highly sensitive blood test could identify traces of the virus linked to the cancer, and that patients with these traces after surgery had a much lower chance of surviving without cancer than those without them. This is important because it shows that tracking these traces can help doctors make better treatment decisions for patients, potentially improving their chances of long-term survival.

View on PubMed

From Smear to Sequence: Using Thyroid Cytology Smear Slides for ThyroSeq Molecular Analysis and Clinicopathologic Insights From 61 Tested Nodules.

2025

Archives of pathology & laboratory medicine

Trabzonlu L, Elliott C, Fisch AS, Chebib IA, Madrigal E

Plain English
Researchers looked at using thyroid cytology smear slides, which are typically used for diagnosing thyroid nodules, for more advanced genetic testing called ThyroSeq. They found that these slides were mostly good enough for DNA analysis, identifying gene mutations and other genetic changes in nearly a third of the tested samples. This is important because it offers a way to gather crucial information about thyroid nodules without needing extra sample procedures, making diagnosis and treatment more efficient.

View on PubMed

Pleomorphic Adenoma with Epithelial Atypia, Apocrine Metaplasia, and/or In situ/Intracapsular Salivary Duct Carcinoma Are Indolent Lesions with Good Prognosis: A Proposal for Unified Nomenclature and Clinical Observation.

2025

Head and neck pathology

Cole GG, Levin M, Ferber D, Roark SC, Sadow PM +8 more

Plain English
Researchers studied different types of tumors found in the salivary glands, specifically looking at certain benign and early-stage cancerous lesions linked to a condition called pleomorphic adenoma. They found that many of these lesions, even with some unusual cell features, do not lead to recurrence or spread of cancer if they remain contained within the tumor. This is important because it suggests that some terms used to describe these lesions might cause unnecessary worry and treatment, and simpler names that reflect their generally harmless nature could be more appropriate.

View on PubMed

Personalized circulating tumor DNA dynamics inform survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancer.

2025

NPJ precision oncology

Ruiz-Torres DA, Merkin RD, Bryan ME, Mendel J, Efthymiou V +11 more

Plain English
Researchers studied patients with a severe type of head and neck cancer that often comes back or spreads. They found that monitoring a specific marker in the blood, known as circulating tumor DNA (ctDNA), can help predict how well patients will respond to treatment and how long they might live. This is important because it offers a new way to tailor treatments to individual patients, potentially improving their chances of survival and minimizing side effects from ineffective therapies.

View on PubMed

GLI1-Altered Tumors of the Ovary: A Report of 4 Cases of an Underrecognized Neoplasm That May Mimic Sex Cord-Stromal Tumors.

2025

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Devins KM, Fisch AS, Young RH, Dias-Santagata D, Oliva E

Plain English
Researchers studied four unusual ovarian tumors with specific genetic changes, finding that they were often mistakenly identified as other types of tumors. All cases shared distinct physical characteristics and genetic markers that set them apart. This matters because recognizing these tumors correctly can improve diagnosis and treatment options for patients, as they may not respond the same way as more common tumor types.

View on PubMed

Direct Comparison of Alternative Blood-Based Approaches for Early Detection and Diagnosis of HPV-Associated Head and Neck Cancers.

2025

Clinical cancer research : an official journal of the American Association for Cancer Research

Bryan ME, Aye L, Das D, Hirayama S, Al-Inaya Y +29 more

Plain English
Researchers studied different blood tests to find a better way to detect head and neck cancers linked to HPV early on. They found that a new blood test technique called whole-genome sequencing (WGS) performed the best, accurately identifying nearly all cases of these cancers compared to existing methods. This matters because catching these cancers early can improve treatment outcomes, and WGS might make it easier to screen for these cancers in the future.

View on PubMed

MicroRNA-mediated PTEN downregulation as a novel non-genetic mechanism of acquired resistance to PI3Kα inhibitors of head & neck squamous cell carcinoma.

2025

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Pulito C, Vaccarella S, Palcau AC, Ganci F, Brandi R +23 more

Plain English
Researchers studied why some head and neck cancers stop responding to a type of treatment called PI3Kα inhibitors. They discovered that certain tiny molecules called microRNAs are responsible for lowering the levels of a protein called PTEN, which helps cells respond to the treatment. This finding is important because it points to new ways to overcome resistance to the treatment by targeting PTEN and related proteins, potentially improving outcomes for patients with these cancers.

View on PubMed

Adult Granulosa Cell Tumors of the Ovary With Tubular Differentiation: A Report of 80 Examples of an Underemphasized Feature With Clinicopathologic and Genomic Differences From Other Sex Cord-Stromal Tumors.

2025

The American journal of surgical pathology

Ray LJ, Young RH, Sabbagh MF, Fisch AS, Oliva E +1 more

Plain English
Researchers studied a specific type of ovarian tumor known as adult granulosa cell tumors (AGCT) that showed features resembling both female and male cell types. They examined 80 cases and found that while these tumors primarily displayed characteristics typical of AGCT, they also contained unique tubular structures, which is unusual. This finding is significant because it helps clarify how these tumors are classified and suggests they may represent a distinct group, aiding in better diagnosis and treatment for patients.

View on PubMed

High-Grade Uterine Sarcoma: First Report of a MEIS2::FOXO4 Fusion.

2025

Genes, chromosomes & cancer

Turashvili G, Choy E, Fisch AS, Oliva E

Plain English
Researchers studied a rare type of uterine cancer called high-grade uterine sarcoma and discovered a new gene fusion (MEIS2::FOXO4) in a patient. This finding, which hasn’t been reported before in uterine sarcomas, shows the importance of analyzing the genetic makeup of these tumors, especially when they appear unusual. Understanding these genetic changes can help improve diagnosis and treatment for patients with rare cancers.

View on PubMed

Targeting Chk1 and Wee1 kinases enhances radiosensitivity of 2D and 3D head and neck cancer models to X-rays and low/high-LET protons.

2025

Cell death & disease

Melia E, Fisch AS, Tinhofer I, Parsons JL

Plain English
Researchers studied the effects of blocking certain proteins, Chk1 and Wee1, on head and neck cancer cells when treated with radiation. They found that using inhibitors of these proteins makes the cancer cells more sensitive to radiation, improving the chances of killing the cancer. This approach could make cancer treatments more effective by combining it with existing radiation therapies.

View on PubMed

Personalized circulating tumor DNA dynamics predict survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancer.

2025

medRxiv : the preprint server for health sciences

Ruiz-Torres DA, Merkin RD, Bryan M, Mendel J, Efthymiou V +11 more

Plain English
Researchers studied how changes in blood samples containing tumor DNA could help predict how well patients with advanced head and neck cancer respond to treatment and how long they might live. They found that when patients had lower levels of this tumor DNA during treatment, they were more likely to respond positively and have better survival rates. This is important because using this DNA information could help doctors make better treatment decisions, potentially improving outcomes for patients.

View on PubMed

High Ano1 expression as key driver of resistance to radiation and cisplatin in HPV-negative head and neck squamous cell carcinoma.

2025

Scientific reports

Bourdier S, Fisch AS, Alp KM, Das R, Mertins P +1 more

Plain English
Researchers studied head and neck cancer that doesn't have the HPV virus, focusing on two genes known to affect treatment response. They found that a gene called Ano1 is linked to poorer survival rates and makes these cancer cells more resistant to common treatments like radiation and chemotherapy. This is important because understanding how Ano1 drives treatment resistance can help doctors develop better treatment options for patients with this type of cancer.

View on PubMed

Multinucleated tumor cells and micropapillary morphology appear to be predictors of poor prognosis in renal cell carcinoma with papillary and oncocytic features.

2024

Human pathology

Zhao T, Denize T, Wang H, Fisch AS, Wu S +2 more

Plain English
Researchers studied a type of kidney cancer known as renal cell carcinoma with papillary and oncocytic features (RCC-PO) to better understand how certain tumor characteristics affect patient outcomes. They found that specific features like micropapillary structures and multinucleated tumor cells are linked to a higher risk of disease spread and worse survival rates. This matters because identifying these features can help doctors predict which patients might have a more aggressive form of the disease and guide treatment decisions.

View on PubMed

Feasibility analysis of using patient-derived tumour organoids for treatment decision guidance in locally advanced head and neck squamous cell carcinoma.

2024

European journal of cancer (Oxford, England : 1990)

Fisch AS, Pestana A, Sachse V, Doll C, Hofmann E +9 more

Plain English
Researchers studied how to use small lab-grown versions of tumors, called organoids, taken from patients with advanced head and neck cancer to help select the best treatments for them. They found that nearly 77% of suitable tumor samples could be successfully grown into organoids, which could then be tested for their response to different therapies. This approach could lead to better treatment decisions and potentially improve survival for patients facing this aggressive cancer.

View on PubMed

Comparative Analysis of MYB Expression by Immunohistochemistry and RNA Sequencing in Clinical Gene Fusion Detection in Adenoid Cystic Carcinoma.

2024

Head and neck pathology

Fisch AS, Farahani AA, Thierauf J, Iafrate AJ, Lennerz JK +1 more

Plain English
Researchers studied the role of a gene called MYB in a type of cancer known as adenoid cystic carcinoma (ACC) by comparing two methods: one that detects MYB protein and another that identifies changes in the MYB gene. They found that the accuracy of detecting MYB protein varies greatly depending on the specific method used, and importantly, a significant number of the cancer cases also showed changes in the MYB gene. This is important because understanding how MYB functions can help improve how doctors diagnose and manage patients with this type of cancer.

View on PubMed

Angiomyolipomatous Lesions of the Nasal Cavity (Sinonasal Angioleiomyoma with Adipocytic Differentiation): A Multi-Institutional Immunohistochemical and Molecular Study.

2024

Head and neck pathology

Jones VM, Thompson LDR, Pettus JR, Green DC, Lefferts JA +8 more

Plain English
Researchers studied rare growths in the nasal cavity that contain blood vessels, smooth muscle, and fat tissue. They found that these growths often occur in older men and typically cause blockage or other symptoms, with most not recurring after removal. This is important because understanding the nature of these growths can help doctors accurately identify and treat similar conditions in the future.

View on PubMed

Angiomyolipomatous Lesions of the Nasal Cavity (Sinonasal Angioleiomyoma with Adipocytic Differentiation): A Multi-Institutional Immunohistochemical and Molecular Study.

2024

Research square

Jones VM, Thompson LDR, Pettus JR, Green DC, Lefferts JA +8 more

Plain English
Researchers looked into rare growths in the nasal cavity that have features of blood vessels, smooth muscle, and fat cells. They found that most of these lesions occurred in older men and often caused nasal blockage, but they generally didn't come back after treatment. This study is important because it clarifies how to classify these unusual growths, which can help doctors better understand and manage them.

View on PubMed

Detection of RAS p.Q61R by Immunohistochemistry in Practice: A Clinicopathologic Study of 217 Thyroid Nodules with Molecular Correlates.

2024

Endocrine pathology

Alzumaili BA, Fisch AS, Faquin WC, Nosé V, Randolph GW +1 more

Plain English
The researchers studied a specific genetic mutation, RAS p.Q61R, in 217 thyroid nodules to see how common it is and how it relates to cancer risk. They found that this mutation appears in a significant percentage of thyroid nodules, but most of the tumors associated with it are low-risk and do not lead to serious health issues. This is important because it shows a reliable and quick way to identify these mutations, helping doctors decide how to monitor and treat patients with thyroid nodules.

View on PubMed

Alterations in Thyroid Carcinoma: A Novel Class of Primary Drivers with Significant Therapeutic Implications and Secondary Molecular Events Potentially Mediating Resistance in Thyroid Malignancy.

2024

Thyroid : official journal of the American Thyroid Association

Sabbagh MF, Janovitz T, Dias-Santagata D, Siegmund S, Nardi V +12 more

Plain English
Researchers studied different types of thyroid cancers to understand specific genetic changes driving these diseases and how they might affect treatment. They found 17 tumors with significant genetic alterations, many of which could lead to new targeted therapies. This matters because recognizing these changes can help doctors choose better treatment options for patients, especially since some of these alterations have not been widely acknowledged before.

View on PubMed

Utility of an anchored multiplex polymerase chain reaction-based fusion assay for diagnosis of soft tissue tumors in cytology.

2024

Cancer cytopathology

Helland TL, Fisch AS, Chebib I

Plain English
Researchers examined a method to improve the diagnosis of soft tissue tumors using fine-needle aspiration samples, which can be tricky due to limited tissue. They found that a specific gene test identified tumors in about 29% of cases, providing crucial information in several instances about the type and spread of the disease. This method can enhance the accuracy of diagnosing these tumors, helping doctors make better treatment decisions.

View on PubMed

Blood-based screening for HPV-associated cancers.

2024

medRxiv : the preprint server for health sciences

Das D, Hirayama S, Aye L, Bryan ME, Naegele S +13 more

Plain English
Researchers studied a blood test designed to detect HPV-related throat cancers years before they usually appear. They found that this test could accurately identify about 79% of patients who would go on to be diagnosed with cancer up to 10 years earlier than traditional methods. This is important because it could lead to earlier diagnosis and treatment, potentially saving lives.

View on PubMed

Outlier Expression of Isoforms by Targeted or Total RNA Sequencing Identifies Clinically Significant Genomic Variants in Hematolymphoid Tumors.

2023

The Journal of molecular diagnostics : JMD

Tsai HK, Gogakos T, Lip V, Tsai JM, Li YD +16 more

Plain English
The researchers studied different gene forms in blood-related cancers to see how they could help predict the severity and type of the disease. They found that certain unusual gene expressions were very effective at identifying significant genetic changes linked to worse or better outcomes in patients. This matters because it can improve how doctors classify these cancers and determine the best treatment strategies for patients based on their genetic profiles.

View on PubMed

Prognostic biomarkers for survival in mucosal melanoma.

2023

Pigment cell & melanoma research

Thierauf JC, Kaluziak ST, Codd E, Dybel SN, Jobbagy S +10 more

Plain English
Researchers studied mucosal melanoma, a rare and aggressive type of skin cancer, to identify factors that impact survival. They found that patients without skin pigmentation and those with specific genetic mutations (NRAS or KRAS) had a shorter lifespan. This matters because it helps doctors predict which patients may have a more serious form of the disease and could lead to more personalized treatment strategies.

View on PubMed

Effectors Enabling Adaptation to Mitochondrial Complex I Loss in Hürthle Cell Carcinoma.

2023

Cancer discovery

Gopal RK, Vantaku VR, Panda A, Reimer B, Rath S +16 more

Plain English
Researchers studied a type of thyroid cancer called Hürthle cell carcinoma, which has specific genetic changes that affect energy production in cells. They discovered that these cancer cells are particularly vulnerable to stress from certain harmful molecules due to their genetic makeup. This finding is important because it could lead to new treatments that target this weakness, potentially improving outcomes for patients with this type of cancer.

View on PubMed

A Comprehensive Study on the Diagnosis and Management of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.

2023

Thyroid : official journal of the American Thyroid Association

Alzumaili BA, Krumeich LN, Collins R, Kravchenko T, Ababneh EI +8 more

Plain English
Researchers studied a type of thyroid tumor called noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) to better understand its diagnosis and treatment. They found that NIFTP rarely led to cancer recurrence after surgery, but the way it was diagnosed often varied, leading to uncertainty in treatment decisions. This highlights the need for clearer guidelines for managing these borderline tumors, which can help doctors take more consistent and effective actions for their patients.

View on PubMed

Molecular Evidence for Olfactory Neuroblastoma as a Tumor of Malignant Globose Basal Cells.

2023

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Zunitch MJ, Fisch AS, Lin B, Barrios-Camacho CM, Faquin WC +8 more

Plain English
Researchers studied a type of nasal cancer called olfactory neuroblastoma (ONB) and found that it is linked to a specific group of stem cells in the nose. They discovered unique markers in ONB that can help distinguish it from similar cancers, which is important for accurate diagnosis. This work is significant because it opens the door to new treatment options targeting the specific cells involved in this cancer, potentially leading to better outcomes for patients.

View on PubMed

Special Considerations in the Molecular Diagnostics of Pediatric Neoplasms.

2022

Clinics in laboratory medicine

Fisch AS, Church AJ

Plain English
The study looks at how to better diagnose and treat cancers in children, which have different genetic features compared to adult cancers. It finds that children's tumors often have specific genetic changes that can affect how we understand and treat these cancers. This is important because developing accurate testing methods tailored for pediatric patients can lead to more effective treatments and better outcomes for young cancer patients.

View on PubMed

Undifferentiated Embryonal Sarcoma of the Liver With Rhabdoid Morphology Mimicking Carcinoma: Expanding the Morphologic Spectrum or a Distinct Variant?

2021

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society

Papke DJ, Fisch AS, Ranganathan S, O'Neill A, Breen M +3 more

Plain English
Researchers studied a rare liver tumor called undifferentiated embryonal sarcoma of the liver (UESL), which mostly affects children. They found a case in a 5-year-old boy where the tumor looked like a different type of cancer but had specific genetic characteristics that confirmed it was UESL. This matters because recognizing these unique features can improve diagnosis and treatment for young patients with similar tumors.

View on PubMed

Intraductal carcinoma of the salivary gland with NCOA4-RET: expanding the morphologic spectrum and an algorithmic diagnostic approach.

2021

Human pathology

Fisch AS, Laklouk I, Nakaguro M, Nosé V, Wirth LJ +4 more

Plain English
Researchers studied a type of salivary gland cancer called intraductal carcinoma (IC) that has a specific genetic change known as NCOA4-RET. They found that this variant of IC can look similar to another cancer type, making it easy to misdiagnose. This is important because accurately identifying these cancers can lead to better treatment options for patients.

View on PubMed

Identification of EWSR1-NFATC2 fusion in simple bone cysts.

2021

Histopathology

Hung YP, Fisch AS, Diaz-Perez JA, Iafrate AJ, Lennerz JK +6 more

Plain English
The researchers studied simple bone cysts, which are non-cancerous growths in the bones of younger people, to better understand their genetic features. They found that some of these cysts contain specific genetic changes, namely EWSR1-NFATC2 fusions, which are typically associated with more aggressive tumors. This discovery is important because it helps differentiate simple bone cysts from other potentially harmful conditions and highlights that not all genetic changes signify cancer.

View on PubMed

Clinical sensitivity and interpretation of PCR and serological COVID-19 diagnostics for patients presenting to the hospital.

2020

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Miller TE, Garcia Beltran WF, Bard AZ, Gogakos T, Anahtar MN +31 more

Plain English
The researchers studied two common COVID-19 tests, PCR and serology, to see how well they work at different stages of the illness in patients at the hospital. They found that the PCR test is very accurate early on but becomes less effective as time passes, while the serology test becomes more accurate over time. This is important because it helps doctors understand when to use each test to get the best results for diagnosing COVID-19.

View on PubMed

Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1-KMT2A-YAP1 and VIM-KMT2A fusions.

2020

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Massoth LR, Hung YP, Nardi V, Nielsen GP, Hasserjian RP +16 more

Plain English
Researchers studied a type of cancer called sarcoma, specifically looking for genetic changes known as KMT2A fusions. They discovered that these fusions often lead to different subtypes of sarcomas, mostly affecting younger adults and exhibiting specific characteristics under the microscope. This finding is important because it helps doctors better understand these rare cancers, potentially improving diagnosis and treatment options for patients.

View on PubMed

Systemic Amyloidosis Mimicking Lung Cancer.

2020

American journal of respiratory and critical care medicine

Fisch AS, Fintelmann FJ, Garcia-Moliner ML, Gaissert HA, Lennes I +3 more

View on PubMed

Genetic Variation in the Platelet Endothelial Aggregation Receptor 1 Gene Results in Endothelial Dysfunction.

2015

PloS one

Fisch AS, Yerges-Armstrong LM, Backman JD, Wang H, Donnelly P +9 more

Plain English
Researchers studied a gene called PEAR1 to understand its role in how blood vessels function. They found that certain genetic variations in PEAR1 can affect the ability of blood vessels to expand and contract, which is crucial for good heart health. This matters because it helps explain how genetic differences can influence the risk of cardiovascular diseases.

View on PubMed

Pharmacogenomics of anti-platelet and anti-coagulation therapy.

2013

Current cardiology reports

Fisch AS, Perry CG, Stephens SH, Horenstein RB, Shuldiner AR

Plain English
This research looks at how people respond differently to blood-thinning medications used to prevent heart attacks and strokes. The study found that genetic factors can significantly influence how well these drugs work for each person. Understanding these genetic differences can help doctors provide more personalized and effective treatment for patients.

View on PubMed

Paraoxonase 1 (PON1) gene variants are not associated with clopidogrel response.

2011

Clinical pharmacology and therapeutics

Lewis JP, Fisch AS, Ryan K, O'Connell JR, Gibson Q +9 more

Plain English
Researchers looked at a specific gene variant in a group of patients to see if it affected how well a heart medication called clopidogrel worked. They found no evidence that this gene variant influenced the drug's effectiveness or related health outcomes. This matters because it suggests that the PON1 gene variant is not a factor in how patients respond to clopidogrel, which can help healthcare providers better understand treatment options.

View on PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.